We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: Oncology Radiopharmaceutical Labeling Must Include Genotoxicity
FDA: Oncology Radiopharmaceutical Labeling Must Include Genotoxicity
Labeling for oncology radiopharmaceuticals must include information on the potential for genotoxicity and adverse reproductive toxicity, the FDA said in new draft guidance.